The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares kick off 2021 with rally on Brexit and vaccine optimism

Mon, 04th Jan 2021 09:24

* UK banks slip after Britain exits EU's orbit

* TUI jumps as CEO expects 'largely normal' summer

* Remy Cointreau slips after Kepler downgrade
(Updates prices throughout, adds comment)

By Amal S and Shreyashi Sanyal

Jan 4 (Reuters) - European shares rallied in the first
trading session of the year on Monday, as a landmark Brexit
trade deal and coronavirus vaccination campaigns across the
continent bolstered expectations of a strong economic rebound.

The pan-regional STOXX 600 index gained 0.7% to
touch fresh February 2020 highs, with economically sensitive
mining jumping more than 3%.

Germany-listed shares in the world's biggest holiday company
TUI rose 2.7% after its chief executive told
a newspaper that he expects "a largely normal summer" this year.

Germany's DAX was up 0.1% after a long weekend to
trade below all-time highs, while France's CAC 40 added
0.7%.

Global stocks hit record highs, with the STOXX 600
recovering about 50% from its March 2020 trough as investors
pinned their hopes on coronavirus vaccines to fuel a speedy
economic bounceback.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

"The distribution of the AstraZeneca-Oxford University
COVID-19 vaccine is also behind the broader positive move in
European stocks," said David Madden, market analyst at CMC
Markets in London.

Adding to the upbeat sentiment, a survey showed German
factories churned out more goods in December despite a stricter
lockdown to head off a spike in coronavirus deaths.

IHS Markit's final Purchasing Managers' Index (PMI) for
manufacturing rose to 58.3 from 57.8 the previous month.

London's blue-chip index gained 1.7% in its first
day of trading with Britain outside the European Union's orbit.

While the hard-fought trade deal agreed late December set
rules for industries such as fishing and agriculture, it did not
cover Britain's much larger finance sector, meaning automatic
access to the EU's financial markets came to an end on Dec. 31.

Shares in UK banks such as Lloyds Banking Group,
Barclays and Natwest fell between 0.7% and 3%,
while the broader European banking index fell 0.8%.

In a bright spot, however, Ladbrokes owner Entain Plc
jumped 25.3% after it confirmed an $11 billion bid
proposal from U.S. casino operator MGM Resorts, which it said
significantly undervalued its business.

UK betting firms like Flutter Entertainment,
William Hill and 888 rose between 2.6% and 3.5%.

French wine and spirits maker Remy Cointreau
slipped 0.2% as brokerage Kepler Cheuvreux downgraded the stock
to "hold" after a U.S. decision last week to impose additional
tariffs on French wines and cognac.
(Reporting by Amal S and Sruthi Shankar in Bengaluru; Editing
by Shailesh Kuber and Lisa Shumaker)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.